CLOV Stock Summary and Trading Ideas (Clover Health Investments Corp. - Class A | NASDAQ:CLOV)

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Clover Health Investments Corp. - Class A trades on the NASDAQ stock market under the symbol CLOV.

As of October 30, 2026, CLOV stock price declined to $4.46 with 4,477,272 million shares trading.

CLOV has a beta of 2.77, meaning it tends to be more sensitive to market movements. CLOV has a correlation of 0.24 to the broad based SPY ETF.

CLOV has a market cap of $2.37 billion. This is considered a Mid Cap stock.

Last quarter Clover Health Investments Corp. - Class A reported $743 million in Revenue and $.05 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $.01.

In the last 3 years, CLOV traded as high as $5.59 and as low as $.61.

The top ETF exchange traded funds that CLOV belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

CLOV has outperformed the market in the last year with a price return of +28.5% while the SPY ETF gained +12.3%. CLOV has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +2.8% and -0.4%, respectively, while the SPY returned +2.1% and -1.0%, respectively.

CLOV support price is $4.40 and resistance is $4.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLOV shares will trade within this expected range on the day.